Even as the raw material cost climbed down from 25% of revenues a year ago to 23% in the September quarter, the other expenses increased from 28% of revenues to nearly 32% in the quarter.
Synopsis
The company’s revenues grew 11% driven by strong growth posted by the India business and the global specialty sales in the US. A third of the company’s revenues is earned each from India and the US. Sun’s market share in India increased from 8.3% to 8.4% for the year ended September 2023.
ET Intelligence Group: India’s largest pharma company’s pivot to global specialty drugs is paying off now. Its September quarter performance was enhanced by the growing traction of its specialty product portfolio. With an 11% surge in revenues and 5% rise in profits, the Street cheered the performance leading to the stock closing 2.5% higher on Wednesday.The company’s revenues grew 11% driven by strong growth posted by the India business and the
BY
ET Bureau
3 mins read, Last Updated:
Gift A Story
Share member-only stories with your friends or family and help them read it for free.
Gifting Limit Reached!
Hey , no more stories left for you to gift.
No worries! You will get a limit of 15 stories next month to share with your friends and family.
Gift This Story
Stories Left!
You can gift upto 15 stories in a month.
FONT SIZE
AbcSmall
AbcMedium
AbcLarge
SAVE
PRINT
COMMENT
Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories & personalised newsletters
Login Now
Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions & in-depth stock reports
Subscribe Now
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Prime Account Detected!
It seems like you’re already an ETPrime member with
Login using your ET Prime credentials to enjoy all member benefits
Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.
To read full story, subscribe to ET Prime
Get Unlimited Access to The Economic Times
₹34 per week
Billed annually at ₹2499 ₹1749
Already a Member? Sign In now
Already a Member? Sign In now
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
Rs 49 for 1st month
Then Rs. 1,749 per year
SUBSCRIBE NOW
Valid only with UPI, Credit & Debit Cards Autopay
Choose Payment Mode & Plan
–
–
–
Subscribe Now
(Credit card mandatory)
You can cancel your subscription anytime
–
–
–
Subscribe Now
(Pay Using Netbanking/UPI/Debit Card)
Netbanking, Credit & Debit Card
Subscribe with Google
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial +Includes DocuBay and TimesPrime Membership.
₹399
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial +Includes DocuBay and TimesPrime Membership.
Get ET Prime for just ₹2499 ₹1749/yr
Offer Exclusively For You
Save up to Rs. 700/-
ON ET PRIME MEMBERSHIP
Avail Offer
Offer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail Offer
Offer Exclusively For You
Get 1 Year Free
With 1 and 2-Year ET prime membership
Avail Offer
Offer Exclusively For You
Get Flat 40% Off
Then ₹ 1749 for 1 year
Avail Offer
Offer Exclusively For You
ET Prime at ₹ 49 for 1 month
Then ₹ 1749 for 1 year
Avail Offer
Special Offer
Get 1200/- off on ETPrime Membership
Avail Offer
To Read the full Story, Subscribe to ET Prime
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
Access the exclusive Economic Times stories, Editorial and Expert opinion
Unlock this story and enjoy all members-only benefits.
Denial of responsibility! Secular Times is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – seculartimes.com. The content will be deleted within 24 hours.
